Accelerated prenatal diagnosis of fragile X syndrome by polymerase chain reaction restriction fragment detection

Am J Med Genet. 1999 Apr 2;83(4):338-41.

Abstract

Prenatal diagnosis of fragile X syndrome requires detection of the full FMR1 mutation in chorionic villus or amniotic fluid cell samples. Although analysis of genomic DNA restriction fragment pattern is a highly reliable technique for identification of the full FMR1 mutation, standard Southern blot determination of this pattern requires significantly more genomic DNA than is initially available from a prenatal sample. To overcome this limitation we developed a method that determines the diagnostic pattern of genomic restriction fragments from a fraction of a prenatal specimen. The prenatal DNA sample is first digested with EcoRI and EagI, and after agarose gel electrophoresis, the 2- to 10-kb region of the gel is serially sectioned and amplified by polymerase chain reaction. Analysis of prenatal samples from an unaffected male and from a full mutation male showed that this approach generated a diagnostic pattern comparable with a Southern blot of 100-fold more material. This innovation enables laboratories to prenatally diagnose the full FMR1 mutation sooner than standard techniques.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blotting, Southern
  • Deoxyribonuclease HindIII
  • Female
  • Fetal Diseases / diagnosis
  • Fetal Diseases / genetics*
  • Fragile X Mental Retardation Protein
  • Fragile X Syndrome / diagnosis
  • Fragile X Syndrome / genetics*
  • Humans
  • Male
  • Nerve Tissue Proteins / genetics*
  • Polymerase Chain Reaction / methods*
  • Pregnancy
  • Prenatal Diagnosis / methods*
  • RNA-Binding Proteins*

Substances

  • FMR1 protein, human
  • Nerve Tissue Proteins
  • RNA-Binding Proteins
  • Fragile X Mental Retardation Protein
  • Deoxyribonuclease HindIII